Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Inhibitory Subunit Of NF kappa B alpha (AA 74-247) protein (His tag)

Origin: Human Host: Escherichia coli (E. coli) Recombinant > 97 % SDS, WB, Imm, PC
Catalog No. ABIN7395020
  • Target
    Inhibitory Subunit Of NF kappa B alpha
    Protein Type
    Recombinant
    Protein Characteristics
    AA 74-247
    Origin
    • 2
    • 1
    Human
    Source
    • 3
    Escherichia coli (E. coli)
    Purification tag / Conjugate
    His tag
    Application
    SDS-PAGE (SDS), Western Blotting (WB), Immunogen (Imm), Positive Control (PC)
    Sequence
    Gly74-Thr247
    Characteristics
    Recombinant Inhibitory Subunit Of NF Kappa B Alpha (IkBa), Prokaryotic expression, Gly74-Thr247, N-terminal His Tag
    Purity
    > 97 %
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Comment

    Isoelectric Point:5.9

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Buffer
    20 mM Tris, 150 mM NaCl, pH 8.0, containing 1 mM EDTA, 1 mM DTT, 0.01 % SKL, 5 % Trehalose and Proclin300.
    Preservative
    ProClin
    Precaution of Use
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-80 °C
    Storage Comment
    Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
    Expiry Date
    12 months
  • Target
    Inhibitory Subunit Of NF kappa B alpha
    Synonyms
    IKBA Protein, MAD-3 Protein, NFKBI Protein, AI462015 Protein, Nfkbi Protein, RL/IF-1 Protein, NFKB inhibitor alpha Protein, nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha Protein, NFKBIA Protein, Nfkbia Protein
    Background
    NFKBIA, IKB-A, MAD-3, NFKBI, Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B-Cells Inhibitor,Alpha, Major histocompatibility complex enhancer-binding protein MAD3
    Molecular Weight
    20kDa
    UniProt
    P25963
You are here: